Avalo Therapeutics, Inc. · NASDAQ:AVTX
Deep Track Capital, LP's stake in Avalo Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Deep Track Capital, LP's stake in Avalo Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 0% | 0 |
| Deep Track Biotechnology Master Fund, Ltd. | 0% | 0 |
| David Kroin | 0% | 0 |
Source
Related
- Avalo Therapeutics, Inc.
- Deep Track Capital, LP
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13G · Deep Track Capital, LP · May 29, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026